Hongene Biotech Corporation’s Post

Great to see the released webinar hosted by lead life science publication Drug Discovery World, and hosted by Reece Armstrong. The webinar is called "What are the challenges and advancements driving CGT drug development?” and has contributions from Ali Pashazadeh, CEO, Treehill Partners, and Erik Digman Wiklund, CEO, Circio Holding ASA . It's available below on demand. Ali explored current barriers and perceptions to the development of #CGTs, examining aspects such as #investment and attitudes towards #scalingup #therapies to treat #diseases such as #cancer. Erik Wiklund discussed how circular RNA #circRNA is crucial to the development of #nextgeneration #celltherapy and #genetherapy products. https://lnkd.in/emTU3QcN

The Fresenius Kabi Cue® can precisely concentrate, wash, dilute, formulate and aliquot cell suspensions. The Cue automates labor-intensive and highly variable tasks in the manufacturing workflow. This automated and functionally closed system will provide cell and gene therapy developers a much-needed solution for their commercial-scale cGMP final fill and finish step. Contact an expert: https://lnkd.in/gZWPCiem #cue #cellprocessing #cellandgenetherapy The Cue Cell Processing System is for laboratory use only and may not be used for direct transfusion. Appropriate regulatory clearance is required by the user for clinical use. Refer to the Cue Cell Processing System User's Guide for a complete list of warnings and precautions associated with the use of this device. For additional information, please visit www.scaleready.com/cue

Thrilled to share I've been featured in the latest issue of Drug Discovery World, discussing 2024 predictions in collaboration with Megan Thomas. We dove deep into the dynamic landscape of cell and gene therapy, revealing its potential to significantly advance treatment options for hard-to-treat diseases.    Check out the full article (pages 8-9 specifically) to explore the groundbreaking insights shaping the future of healthcare.    #drugdiscovery #2024predictions #cellandgenetherapy #healthcareinnovation

Kicking off #CGmesa24 with a 💥! Bristol Myers Squibb’s Lynelle Hoch led a stellar and wide-ranging Fireside Chat with Former FDA Commissioner Scott Gottlieb on the history of #CART and the ongoing challenges & opportunities to advance and democratize #access to #innovative #cell and #gene therapies. Gottlieb’s new book “The Miracle Century: Making Sense of the Cell Therapy Revolution” will be out in 2025. His predictions for the near to mid term include: 🔬Clinical results of CAR T for #Autoimmune Diseases maturing and leading to safer regimens 🔬Dual therapy for #solidtumors (drugs to shrink and next-gen CAR T to eliminate the tumor) 🔬Continued success in treating intractable common diseases such as Type I #Diabetes and #Parkinson’s including the exciting efforts by BlueRock Therapeutics and Bayer #CART #celltherapy #genetherapy Alliance for Regenerative Medicine

The European Society for Medical Oncology congress is next week! Join us to learn how we are putting a new spin on whole genome sequencing! Want to meet up and learn more about the UG 100™? Sign up for a meeting here: 👉 https://lnkd.in/gz7BnUfs #ESMO24 #NGS #WGS #Sequencing #UltimaGenomics #UG100

Hot on the heels of today's first new publication looking at lentiviral vectors, we've another exploring the role of RNA based therapies in the management of Urea Cycle Disorders. Urea Cycle Disorders are particularly amenable to many of the benefits that such technologies offer and RNA based approaches may be very helpful for bridging issues seen with AAV vector delivery, notably the duration of action and limits around re-dosing. Plus there's another #visualabstract. Thank you wonderful authors. Exploring RNA therapeutics for urea cycle disorders Eva Richard, Ainhoa Martinez Pizarro, Lourdes Ruiz Desviat https://lnkd.in/enyTvSt6 #OTC #ureacylcledisorders #thinkammonia #checkammonia

Uncover the potential of RNA therapeutics in tackling neurodegenerative diseases, cancers, and more. Discover how to optimize your RNA research and therapeutic development for downstream success with our upcoming webinar. What you'll learn: - Applications of RNA oligos in research & therapeutic development - Best practices for overcoming RNA oligo challenges - Emerging RNA modalities & future possibilities Save your spot: https://hubs.ly/Q02HDb930 #RNATherapeutics #DrugDevelopment #Therapeutics #RNA

🎬 Introducing a brand new video series called "Tom's Top 3"! Join me as I delve into the latest buzz in healthcare innovation, highlighting three captivating stories shaping the industry. In our inaugural episode, we'll be exploring: 1️⃣ Groundbreaking gene therapies revolutionizing rare disease treatments. 2️⃣ Big moves in biologics manufacturing with significant acquisitions. 3️⃣ Impactful collaborations driving progress in pediatric cancer care. Insights into further stories to highlight over the coming weeks will be greatly appreciated! Stay tuned and let's embark on this journey together. #TomsTop3 #HealthcareUpdates #Innovation #LinkedInCommunity 🚀🩺 Links to the full articles can be found in the comments!

🌟 Voices Behind the Alliance 🌟 For future generations of women, world-leading Monash University lupus expert Professor Eric Morand and his team are working towards addressing the key issues that have made outcomes for patients with Lupus so poor. Over the next five years, he is determined to discover prototype drugs to replace the use of steroids in Lupus treatment, perform clinical trials of antigen-specific cell therapies and study the genomic basis of Lupus. Click the link below to learn more about Professor Eric Morand’s first targeted treatment for Lupus listed on the PBS. https://lnkd.in/gX2Bxx3u #Lupus #Autoimmunedisease #Lupusresearch

Social Pharma Patient-Centric Marketing socialpharma.net >>> Gene&Cell Therapy >> ProKidney axes one Phase 3 study, aims for 'expedited approval pathway' using another #lucidquest #genetherapy #celltherapy